Crinetics Pharmaceuticals, Inc.: cashflow_financing
| Value | {"amount": 351019000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"} |
|---|---|
| Period | 2023-01-01 – 2023-09-30 |
| Status | current |
| Entity | Crinetics Pharmaceuticals, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T17:04:12.218403+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/ad8ed926-069b-4ada-8138-a04d11791ae5
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0000950170-23-060254Retrieved: 2026-08-19T17:04:12.218403+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001658247/cashflow-financing/2023-09-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/ad8ed926-069b-4ada-8138-a04d11791ae5
History
- no predecessors — first report